Giuseppe Nunnari to Coronavirus Infections
This is a "connection" page, showing publications Giuseppe Nunnari has written about Coronavirus Infections.
Connection Strength
0.123
-
Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis. Eur Rev Med Pharmacol Sci. 2021 03; 25(6):2473-2474.
Score: 0.029
-
Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection. Exp Cell Res. 2020 10 15; 395(2):112204.
Score: 0.028
-
Outbreak of COVID-19 infection in children: fear and serenity. Eur Rev Med Pharmacol Sci. 2020 04; 24(8):4572-4575.
Score: 0.027
-
Asymptomatic COVID-19 infection in patients with cancer at a cancer-specialized hospital in Wuhan, China - Preliminary results. Eur Rev Med Pharmacol Sci. 2020 11; 24(21):10924-10925.
Score: 0.007
-
A Case of COVID-19 with Late-Onset Rash and Transient Loss of Taste and Smell in a 15-Year-Old Boy. Am J Case Rep. 2020 Aug 20; 21:e925813.
Score: 0.007
-
Editorial - Coronavirus disease 2019 and people living with HIV: clinical considerations. Eur Rev Med Pharmacol Sci. 2020 07; 24(13):7534-7539.
Score: 0.007
-
Transmission mode associated with coronavirus disease 2019: a review. Eur Rev Med Pharmacol Sci. 2020 07; 24(14):7889-7904.
Score: 0.007
-
Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci. 2020 03; 24(5):2781-2783.
Score: 0.007
-
In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention? Eur Rev Med Pharmacol Sci. 2020 04; 24(7):3434-3436.
Score: 0.002
-
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. Eur Rev Med Pharmacol Sci. 2020 04; 24(7):4040-4047.
Score: 0.002